Curis
CRIS
#11066
Rank
C$6.95 M
Marketcap
C$1.04
Share price
-18.65%
Change (1 day)
-43.36%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -C$12.48 Million

According to Curis's latest financial reports the company's current earnings are C$4.31 Million. In 2025 the company made an earning of -C$7.63 Million, an increase over its 2024 earnings that were of -C$60.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$12.48 Million63.71%
2025 -C$7.63 Million-87.38%
2024 -C$60.4 Million-5.77%
2023 -C$64.1 Million-13.1%
2022 -C$73.76 Million27.52%
2021 -C$57.84 Million65.09%
2020 -C$35.04 Million-9.1%
2019 -C$38.54 Million-4.73%
2018 -C$40.46 Million-41.95%
2017 -C$69.68 Million-14.37%
2016 -C$81.38 Million3.55%
2015 -C$78.58 Million271.52%
2014 -C$21.16 Million76.64%
2013 -C$11.98 Million
2011 -C$10.17 Million27.76%
2010 -C$7.96 Million-43.87%
2009 -C$14.19 Million-23.44%
2008 -C$18.53 Million56.66%
2007 -C$11.83 Million-16.71%
2006 -C$14.2 Million-36.92%
2005 -C$22.51 Million156.25%
2004 -C$8.79 Million-37.24%
2003 -C$14 Million-93.34%
2002 -C$0.22 Billion86.79%
2001 -C$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$9.75 B-81,859.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$15.99 B-134,238.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-C$87.37 Million 632.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$1.50 B-12,716.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.47 Billion 3,756.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-C$31.43 Million 163.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-C$0.14 Billion 1,025.71%๐Ÿ‡บ๐Ÿ‡ธ USA